Cui Jingrong Jean
President and CEO, Director, 10% Owner
3 filings on record here, covering BLSM, BCAL, AGIG. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-10
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
| Award | BLSM | BlossomHill Therapeutics, Inc. | |
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
| Convert | BLSM | BlossomHill Therapeutics, Inc. | |
CORPORATEFiled 2026-08-03
| Tax | BCAL | California BanCorp \ CA | $14,995 |
CORPORATEFiled 2026-06-26
| Award | AGIG | ABUNDIA GLOBAL IMPACT GROUP, INC. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.